Therefore, therapeutic approaches to elevate the levels of these lipid mediators, as in the case of sEH inhibition, are useful for treating different inflammatory disorders such as diabetes, atherosclerosis, and arthritis [67,99,100,101,102]. Here, EPHX2 is linked to diabetes mellitus.